Priya Sachdeva

Stock Analyst at UBS

(1.07)

# 3,791

Out of 4,980 analysts

5

Total ratings

40%

Success rate

-4.58%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$271.98	+23.17%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$9.67	+75.80%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $271.98

Upside: +23.17%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $9.67

Upside: +75.80%